Kaplan Fox Reminds Investors of Smartsheet Inc. (NYSE: SMAR) to a Securities Class Action Deadline - Contact the Firm Before October 5, 2026

A securities class action was filed against Smartsheet (NYSE: SMAR) for alleged stock-repurchase practices during June 1, 2024 to September 23, 2024, coinciding with knowledge of a formal acquisition offer from a Blackstone and Vista consortium. The complaint alleges Smartsheet should have disclosed the offer or abstained from buying shares at prices below the purported offer level, which could raise litigation overhang and investor concerns around deal process and disclosures. The news is likely to be a modest negative for sentiment but not a major immediate driver of trading without deal or financial updates.

Analysis

This is mostly a distributional event, not an operating one. Any cash cost should sit with the D&O tower or deal-related indemnities, so the direct P&L hit to the sponsor side is likely immaterial unless discovery uncovers board-level documents that materially strengthen scienter. For BX, the bigger issue is not dollars but process friction: future take-private processes may carry a slightly higher disclosure burden and slower buyback behavior around strategic reviews, which can modestly reduce flexibility in deal execution.

The market mechanism is second-order: litigation like this can make software boards less willing to repurchase stock when an M&A process is plausible, which can widen the gap between intrinsic value and public-market pricing in small/mid-cap software. That said, the incremental discount to BX or other sponsors is probably tiny unless this becomes a pattern across multiple deals and starts showing up in underwriting spreads for D&O coverage or in sponsor bid-ask behavior.

Time horizon matters. Over days, this should be ignored; over 1-3 months, only the class-certification / motion-to-dismiss path can keep it alive as a headline overhang. Over 6-18 months, the only real bearish case is a broader regulatory or plaintiff-friendly precedent that makes buybacks during strategic alternatives reviews harder to execute. Contrarian view: the consensus may be overstating legal damage and understating how quickly these cases settle for amounts that are noise relative to sponsor economics.

Key Decisions for Investors

• No standalone trade in BX or SMAR on this headline alone; treat as legal noise unless the complaint survives dismissal with damaging internal-doc evidence.
• Set a watch item on BX relative performance versus KKR/CG/TPG over the next 2-4 weeks; if BX underperforms by >1% on litigation headlines without new facts, fade the move with a long-BX/short-basket peer pair.
• Monitor D&O insurers and litigation-heavy software names for spillover, but do not add exposure unless we see a broader repricing in primary insurance rates or a cluster of similar M&A disclosure cases.
• If a future filing reveals board minutes or banker emails showing knowledge of a signed bid during repurchases, reassess with a bearish BX trading stance; absent that, expected value is too small for an option expression.